(52 days)
Not Found
Not Found
No
The 510(k) summary describes a sterile ultrasound couplant and lubricant, which is a physical substance used to facilitate ultrasound imaging. There is no mention of software, algorithms, or any computational processing that would involve AI or ML. The "Mentions AI, DNN, or ML" section explicitly states "Not Found".
No
The device is described as an ultrasound couplant and lubricant for diagnostic imaging, not for treating a condition.
No
This device is described as an "ultrasound couplant and lubricant" intended to facilitate imaging, not to diagnose conditions itself. It is used "in conjunction with" diagnostic procedures.
No
The device description clearly states that VivoSonic™ is a "sterile ultrasound couplant and lubricant," which is a physical substance, not software.
Based on the provided information, no, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This testing is done outside the body (in vitro).
- VivoSonic™'s Function: VivoSonic™ is an ultrasound couplant and lubricant used during medical imaging procedures. Its purpose is to facilitate the transmission of sound waves into and out of the body and to lubricate the insertion of devices. It does not analyze or test specimens taken from the body.
- Intended Use: The intended use clearly states it's for "coupling sound waves between patient and medical imaging electronics" and "lubricate the insertion and passage of imaging devices." This is a direct interaction with the patient's body during an imaging procedure, not an in vitro test.
Therefore, VivoSonic™ falls under the category of a medical device used in vivo (within the living body) to aid in diagnostic imaging, but it is not an IVD.
N/A
Intended Use / Indications for Use
VivoSonic™ will be used during invasive medical diagnostic ultrasound imaging to couple sound waves between patient and medical imaging electronics and to lubricate the insertion and passage of imaging devices, such as ultrasound transducers and endoscopes.
VivoSonic™ is intended for use in conjunction with transcutaneous ultrasound image guided biopsy and aspiration, intraoperative ultrasound imaging, endocavity ultrasound imaging and opthalmic ultrasound imaging.
VivoSonic™ is unit dose packaged, sterilized and intended for use in all diagnostic ultrasound procedures which currently use and ultrasound coupling gel or fluid alone or in combination with a latex, non-latex, polyurethane or polyethylene transducer cover where sterility and/or in vivo biocompatibility are required.
Product codes (comma separated list FDA assigned to the subject device)
90 MUI
Device Description
VivoSonic™ is an in vivo biocompatible sterile ultrasound couplant and lubricant that couples or conducts ultrasound between the body and the ultrasound transducer and electronics.
The VivoSonic™ formulation is in vivo biocompatible with tissue and body fluids and is recognized as safe for oral administration (1)
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
ultrasound imaging
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1570 Diagnostic ultrasonic transducer.
(a)
Identification. A diagnostic ultrasonic transducer is a device made of a piezoelectric material that converts electrical signals into acoustic signals and acoustic signals into electrical signals and intended for use in diagnostic ultrasonic medical devices. Accessories of this generic type of device may include transmission media for acoustically coupling the transducer to the body surface, such as acoustic gel, paste, or a flexible fluid container.(b)
Classification. Class II.
0
MAY 1 6 2002
KO20956
Premarket Notification (510k) Summary
Microtek Medical, Inc. 512 Lehmberg Road Columbus, Mississippi 39702
Telephone: 662-327-1863
Contact Person: Thomas Bonner Date compiled: March 15, 2002
1
Image /page/1/Picture/1 description: The image shows a logo for Microtek Medical, Inc. The logo features a stylized "M" with a circle above it, and the words "MICROTEK MEDICAL, inc." printed below. To the left of the "M" is a faded image of the words "IT SYSTEM".
Premarket Summary
Device Name
Proprietary name: VivoSonic™
Common name: In vivo biocompatible, sterile medical diagnostic ultrasound imaging coupling media.
Establishment Registration Number: 1043582 (Microtek Medical, Inc.)
Classification: II
Statement of Substantial Equivalence
VivoSonic™ is equivalent in ultrasound imaging coupling performance to:
-
- Aquasonic 100 sterile (Parker Laboratories, Inc.)
-
- Ultra/Phonic sterile (Pharmaceutical Innovations)
-
- Natural Image (Sontotech, Inc.)
Description of Device
VivoSonic™ is an in vivo biocompatible sterile ultrasound couplant and lubricant that couples or conducts ultrasound between the body and the ultrasound transducer and electronics.
The VivoSonic™ formulation is in vivo biocompatible with tissue and body fluids and is recognized as safe for oral administration (1)
Intended Use
VivoSonic™ will be used during invasive medical diagnostic ultrasound imaging to couple sound waves between patient and medical imaging electronics and to lubricate the insertion and passage of imaging devices, such as ultrasound transducers and endoscopes.
VivoSonic™ is intended for use in conjunction with transcutaneous ultrasound image guided biopsy and aspiration, intraoperative ultrasound imaging, endocavity ultrasound imaging and opthalmic ultrasound imaging.
VivoSonic™ is unit dose packaged, sterilized and intended for use in all diagnostic ultrasound procedures which currently use and ultrasound coupling gel or fluid alone or in combination with a latex, non-latex, polyurethane or polyethylene transducer cover where sterility and/or in vivo biocompatibility are required.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines forming its body and head. The eagle faces to the left. Encircling the eagle is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 1 6 2002
Mr. Thomas B. Bonner , Jr. Vice President, Regulatory Affairs/Quality Assurance MICROTEK Medical, Inc. 512 Lehmberg Road COLUMBUS MS 39702
Re: K020956
Trade/Device Name: VivoSonic™ Diagnostic Ultrasound Imaging Coupling Media Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic Ultrasonic transducer Regulatory Class: II Product Code: 90 MUI Dated: March 15, 2002 Received: March 25, 2002
Dear Mr. Bonner:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
3
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use Statement
and the same of the same of the same of the same of the same of the same of the states of the states of the states of the states of the states of the states of the states of
,
510(k) Number
:
| Device Name: | Microtek Medical, Inc. VivoSonic Diagnostic Ultrasound Imaging Coupling Media |
|---|---|
| Indications for Use Statement: | VivoSonic Media is used during invasive medical diagnostic ultrasound imaging to couple sound waves between the patient and the medical imaging electronics, and to lubricate the insertion and passage of imaging devices. |
| VivoSonic Media is used in conjunction with transcutaneous ultrasound imaging guided biopsy and apsiration, intraoperative ultrasound imaging, endocavity ultrasound imaging, and opthalmic ultrasound imaging. | |
| VivoSonic Media is intended for use in all diagnostic ultrasound procedures which currently use an ultrasound gel or fluid alone or in combination with a latex, non-latex, polyurethane or polyethylene transducer cover where sterility and vivo biocompatibility are required. |
PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | ||
|---|---|---|
| Division of Cardiovascular, Respiratory, And Neurological Devices | ||
| 510(k) Number | ||
| Prescription Use (per 21CFR 801.109) | ✓ or Over-The-Counter Use | ✓ or Over-The-Counter Use |
| ✓ or Over-The-Counter Use | ||
| (Division Sign-Off) | ||
| Division of Reproductive, Abdominal, and Radiological Devices | ||
| 510(k) Number R020956 |